4.6 Review

Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications

Nikita A. Frolov et al.

Summary: This article summarizes recent scientific literature on intra- and intermolecular reactions leading to the formation of various piperidine derivatives. It also covers the pharmaceutical applications of synthetic and natural piperidines, as well as the latest scientific advances in the discovery and biological evaluation of potential drugs containing piperidine moiety. The review aims to assist both novice researchers and experienced scientists in the synthesis of biologically active piperidines.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Neurosciences

Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer's Disease

Astik Kumar et al.

Summary: It is alarming that 55 million people worldwide are estimated to be affected by Alzheimer's disease (AD), with 10 million new cases each year. The lack of a permanent medication for neurodegenerative disorders like AD highlights the need for improved research and treatment. The complexity of the brain's structure, particularly the blood-brain barrier, poses challenges in drug delivery. Various approaches, such as oral, intravenous, gene delivery, and liposomal hydrogels, can be utilized to transport drug molecules to the brain. This article provides an overview of recent advances in brain drug delivery for AD therapy.

BRAIN SCIENCES (2023)

Review Chemistry, Medicinal

Review of β-carboline and its derivatives as selective MAO-A inhibitors

Feba Benny et al.

Summary: As FAD-dependent enzymes, monoamine oxidases (MAOs) catalyze the oxidation of amines and MAO-A inhibitors are considered effective therapeutic agents for neurological diseases. Beta-carbolines have recently been discovered to have highly effective and specific MAO-A inhibitory activity, making them a potential new class of inhibitors. This review discusses the structure-activity relationship of beta-carboline and its analogs, providing valuable information for the development of new MAO-A inhibitors for depressive disorders.

ARCHIV DER PHARMAZIE (2023)

Review Biochemistry & Molecular Biology

A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics

Richard N. L. Lamptey et al.

Summary: Neurodegenerative disorders are characterized by neuron loss. Most current treatments only alleviate associated symptoms due to the limited effectiveness of drugs crossing the blood-brain barrier. Nanoparticles offer a promising approach for targeted drug delivery to the brain.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Chemistry, Medicinal

Revealing the role of the benzyloxy pharmacophore in the design of a new class of monoamine oxidase-B inhibitors

Sachithra T. Sudevan et al.

Summary: This review article focuses on the potential application of monoamine oxidase (MAO) inhibitors in the treatment of neurological disorders. It provides a comprehensive summary of the innovative conceptual prospects, chemistry, and bioactivity of MAO inhibitors. The benzyloxy moiety attached to various scaffolds has been identified as a pivotal component in the inhibition of MAO.

ARCHIV DER PHARMAZIE (2022)

Article Chemistry, Multidisciplinary

Conjugated Dienones from Differently Substituted Cinnamaldehyde as Highly Potent Monoamine Oxidase-B Inhibitors: Synthesis, Biochemistry, and Computational Chemistry

Bijo Mathew et al.

Summary: Fifteen multiconjugated dienones were synthesized and evaluated for their inhibitory activities against MAO-A and MAO-B. The compounds showed potent and highly selective inhibition of MAO-B. MK6 and MK12 exhibited the most effective inhibition of MAO-B, with high selectivity indices. The study concluded that these compounds have potential as neurodegenerative disorder treatments.

ACS OMEGA (2022)

Review Chemistry, Multidisciplinary

Exploration of the Detailed Structure-Activity Relationships ofIsatin and Their Isomers As Monoamine Oxidase Inhibitors

Sunil Kumar et al.

Summary: Monoamine oxidase (MAO) is a key protein involved in the metabolism of neuroamines and has emerged as a potential drug target for neurodegenerative diseases. Isatin, a reversible inhibitor for MAO enzymes, shows high selectivity for MAO-B. This comprehensive review discusses the structure-activity relationships of isatins and their analogues for the design and development of new MAO inhibitors for neurodegenerative diseases.

ACS OMEGA (2022)

Review Biochemistry & Molecular Biology

Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma

Narayan D. Chaurasiya et al.

Summary: Monoamine oxidase inhibitors (MAOIs) are important drugs for treating depression and neurological disorders, with natural product MAOIs showing potential as safer alternatives. Traditional plants and herbal formulations containing MAOI constituents have psychoactive and neuroprotective effects, indicating therapeutic potential for neuroblastoma treatment.

MOLECULES (2022)

Article Psychology, Clinical

Clinically Relevant Drug Interactions with Monoamine Oxidase Inhibitors

Amber N. Edinoff et al.

Summary: Monoamine oxidase inhibitors (MAOI) are drugs used for the treatment of depression and other affective and neurological disorders. They work by inhibiting the monoamine oxidase enzyme, which prevents the breakdown of neurotransmitters such as dopamine and serotonin. It is important to be aware of the potential interactions with certain foods and other medications when using MAOIs to avoid serious side effects.

HEALTH PSYCHOLOGY RESEARCH (2022)

Article Chemistry, Multidisciplinary

Diastereoselective hydrogenation of arenes and pyridines using supported ruthenium nanoparticles under mild conditions

Florian Bourriquen et al.

Summary: A convenient and practical diastereoselective cis-hydrogenation method for multi-substituted pyridines and arenes was reported. The use of a novel heterogeneous ruthenium catalyst resulted in high yields (typically >80%) of corresponding piperidines and cyclohexanes with good functional group tolerance under mild conditions. The robust ruthenium supported catalyst can be easily prepared and reused multiple times without loss of activity.

CHEMICAL COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door

Bijo Mathew et al.

Summary: The use of halogens in drug structures plays a significant role in modulating their physical-chemical properties and enzymatic selectivity, especially through the formation of halogen bonds at active sites. This review highlights the impact of halogens on Monoamine Oxidase activity and isozyme selectivity.

CURRENT MEDICINAL CHEMISTRY (2021)

Article Cell & Tissue Engineering

Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer's patients

Jerome Mertens et al.

Summary: Our study identifies AD-related neuronal changes as age-dependent cellular programs that impair neuronal identity.

CELL STEM CELL (2021)

Review Pharmacology & Pharmacy

Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action

Mahyar Ostadkarampour et al.

Summary: Chronic inflammatory diseases have a significant impact on patients' quality of life and financial burden. Monoamine oxidase (MAO) inhibitor drugs have been shown to have anti-inflammatory effects, not only in CNS-associated diseases, but also in various non-CNS tissues. Understanding the mechanism(s) of action of MAO inhibitors is critical for their development as anti-inflammatories.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Deciphering the detailed structure-activity relationship of coumarins as Monoamine oxidase enzyme inhibitors-An updated review

Vishal Payyalot Koyiparambath et al.

Summary: In recent years, Monoamine oxidase (MAO) has become a target for treating neurodegenerative diseases such as anxiety, depression, Alzheimer's, and Parkinson's diseases. Coumarins, known for their ease of synthesis, high therapeutic potential, and reversibility in inhibiting MAOs, are considered potent scaffold among several classes of inhibitors. This review focuses on the research in this field from 2014 to 2020, with a major emphasis on the structure-activity relationship of coumarin derivatives.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

Article Biochemistry & Molecular Biology

Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach

Aathira Sujathan Nair et al.

Summary: The study revealed that halogen substitutions on pyrazoline compounds exhibited potent inhibitory activities against human monoamine oxidase-A and -B, with EH7 showing the highest potency against MAO-B. EH7 was found to have a high selectivity index and act as a reversible and competitive inhibitor of MAO-B, indicating its potential for the development of lead molecules for treating neurodegenerative disorders.

MOLECULES (2021)

Review Chemistry, Multidisciplinary

Current Progress in Quinazoline Derivatives as Acetylcholinesterase and Monoamine Oxidase Inhibitors

Nisha Abdul Rehuman et al.

Summary: This review focuses on recent advances in quinazoline derivatives as inhibitors of AChE and MAO, highlighting their molecular determinants and structure-activity relationships on AChE and MAO inhibitory potencies.

CHEMISTRYSELECT (2021)

Review Chemistry, Multidisciplinary

The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020

Rzgar Tawfeeq Kareem et al.

Summary: Dementia is a term used to describe various brain disorders that affect memory, cognition, behavior, and emotions. Alzheimer's disease is the second leading cause of dementia, characterized by the death of cholinergic neurons and commonly treated with acetylcholinesterase inhibitors. Scientists are exploring the development of hybrid molecules and multitarget-directed ligands to target multiple biological pathways in the rational design of new potential Alzheimer's medications.

RSC ADVANCES (2021)

Article Chemistry, Organic

Acid-catalyzed, regioselective [3+3] annulation of enaminones and α-substituted cinnamic acids: access to 3,4-dihydropyridones and 2-piperidinones

Sivanna Chithanna et al.

Summary: An efficient strategy for synthesizing structurally diverse 3,4-dihydropyridones and 2-piperidinones is described in this study. The former is prepared through acid-catalyzed Michael addition of enaminones to electron-deficient alpha-substituted cinnamic acids followed by lactamization, while the latter is synthesized through the same methodology using coumarin 3-carboxylic acids instead of cinnamic acids. The unique regioselective reactivity of enaminones towards different cinnamic acid derivatives is highlighted.

ORGANIC & BIOMOLECULAR CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Galectin-3 promotes Aβ oligomerization and Aβ toxicity in a mouse model of Alzheimer's disease

Chih-Chieh Tao et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Biochemistry & Molecular Biology

Combination Drug Therapy for the Management of Alzheimer's Disease

Md. Tanvir Kabir et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Chemistry, Organic

Synthetic approaches toward piperidine related structures: A review

Ayesha Bari et al.

SYNTHETIC COMMUNICATIONS (2020)

Article Chemistry, Multidisciplinary

Hydrogenation of Pyridines Using a Nitrogen-Modified Titania-Supported Cobalt Catalyst

Feng Chen et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Review Neurosciences

Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism

Pauline Vercruysse et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Review Chemistry, Medicinal

Recent advancement of piperidine moiety in treatment of cancer- A review

Pallavi Goel et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Cell Biology

Pathology of Neurodegenerative Diseases

Brittany N. Dugger et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)

Review Biochemical Research Methods

Structural Exploration of Synthetic Chromones as Selective MAO-B Inhibitors: A Mini Review

Bijo Mathew et al.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2017)

Article Psychology, Biological

A Brief History of the Development of Antidepressant Drugs: From Monoamines to Glutamate

Todd M. Hillhouse et al.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2015)

Article Pharmacology & Pharmacy

Inhibitor Design for Monoamine Oxidases

Rona R. Ramsay

CURRENT PHARMACEUTICAL DESIGN (2013)

Article Chemistry, Medicinal

Synthesis and inhibitory effect of piperine derivates on monoamine oxidase

Li-Hua Mu et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)

Article Chemistry, Medicinal

Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases

Taufiq Rahman et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Review Cell Biology

Basic mechanisms of neurodegeneration: a critical update

Kurt A. Jellinger

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)

Review Clinical Neurology

Classification and basic pathology of Alzheimer disease

Charles Duyckaerts et al.

ACTA NEUROPATHOLOGICA (2009)

Review Biochemistry & Molecular Biology

Molecular Pathology of Human Prion Diseases

Gabor G. Kovacs et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)

Review Biochemistry & Molecular Biology

Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders

Yahya E. Choonara et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)

Article Chemistry, Medicinal

Methylpiperate derivatives from Piper longum and their inhibition of monoamine oxidase

Seon A. Lee et al.

ARCHIVES OF PHARMACAL RESEARCH (2008)

Article Multidisciplinary Sciences

Structure of human monoamine oxidase A at 2.2-Å resolution:: The control of opening the entry for substrates/inhibitors

Se-Young Son et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Biochemistry & Molecular Biology

Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B

Dale E. Edmondson et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)

Review Medicine, General & Internal

Thioridazine for schizophrenia (Withdrawn Paper. 2007, art. no. CD001944)

M. Fenton et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)

Article Plant Sciences

Antidepressant-like effects of piperine and its derivative, antiepilepsirine

Song Li et al.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH (2007)

Review Medicine, General & Internal

Benperidol for schizophrenia

S Leucht et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)

Article Plant Sciences

Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones

LD Kong et al.

JOURNAL OF ETHNOPHARMACOLOGY (2004)